Excess thyroid hormone and carbohydrate meta bolism

Endocrine Practice

Volumn 15, Issue 3, 2009, Pages 254-262

  Potenza, Matthew ^a,c   Via, Michael A ^b   Yanagisawa, Robert T ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADIPOCYTOKINE; GLUCOSE; GLUCOSE DEGRADATION PRODUCT; GLYCOGEN; SULFONYLUREA; THIAMAZOLE; THYROID HORMONE;

ADIPOSE TISSUE; AEROBIC METABOLISM; AGED; ANAEROBIC METABOLISM; CARBOHYDRATE METABOLISM; CASE REPORT; DIABETIC KETOACIDOSIS; DISEASE PREDISPOSITION; ELECTROCARDIOGRAPHY; FEMALE; GLUCOSE HOMEOSTASIS; GRAVES DISEASE; HEART ATRIUM FIBRILLATION; HORMONE ACTION; HUMAN; HYPERTHYROIDISM; INFORMATION RETRIEVAL; INSULIN CLEARANCE; KETOACIDOSIS; KIDNEY CLEARANCE; LIVER; MEDLINE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS; PATIENT COMPLIANCE; REVIEW; SKELETAL MUSCLE; THYROID CRISIS; THYROID FUNCTION; THYROTOXICOSIS;

EID: 67649224786     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.15.3.254     Document Type: Review

References (72)

1. Burch HB, Wartofsky L. Life-threatening thyrotoxicosis. Thyroid storm. Endocrinol Metab Clin North Am. 1993;22: 263-277.
2. Perros P, McCrimmon RJ, Shaw G, Frier BM. Frequency of thyroid dysfunction in diabetic patients: value of annual screening. Diabet Med. 1995;12:622-627.
3. Santamaria P, Barbosa JJ, Lindstrom AL, Lemke TA, Goetz FC, Rich SS. HLA-DQB1-associated susceptibility that distinguishes Hashimoto's thyroiditis from Graves' disease in type I diabetic patients. J Clin Endocrinol Metab. 1994;78:878-883.
4. Wu P. Thyroid disorders and diabetes. It is common for a person to be affected by both thyroid disease and diabetes. Diabetes Self Manag. 2007;24:80-82, 85-87.
5. Paul DT, Mollah FH, Alam MK, Fariduddin M, Azad K, Arslan MI. Glycemic status in hyperthyroid subjects. Mymensingh Med J. 2004;13:71-75.
6. Stamp TC, Doar JW, Wynn V. Observations on some effects of L-triiodothyronine on carbohydrate and lipid metabolism in man. J Clin Pathol. 1969;22:132-135.
7. Kreines K, Jett M, Knowles HC Jr. Observations in hyperthyroidism of abnormal glucose tolerance and other traits related to diabetes mellitus. Diabetes. 1965;14:740-744.
8. Bhattacharyya A, Wiles PG. Diabetic ketoacidosis precipitated by thyrotoxicosis. Postgrad Med J. 1999;75:291-292.
9. Bridgman JF, Pett S. Simultaneous presentation of thyrotoxic crisis and diabetic ketoacidosis. Postgraduate Med J. 1980;56:354-355.
10. Kunishige M, Sekimoto E, Komatsu M, Bando Y, Uehara H, Izumi K. Thyrotoxicosis masked by diabetic ketoacidosis: a fatal complication. Diabetes Care. 2001;24:171.
11. Lee HL, Yu E, Guo HR. Simultaneous presentation of thyroid storm and diabetic ketoacidosis. Am J Emerg Med. 2001;19:603-604.
12. Lim D, Lunt H, Ojala R, Turner J. Simultaneous presentation of type 1 diabetes and thyrotoxicosis as a medical emergency. N Z Med J. 2004;117:U775.
13. Lin CH, Chen SC, Lee CC, Ko PC, Chen WJ. Thyroid storm concealing diabetic ketoacidosis leading to cardiac arrest. Resuscitation. 2004;63:345-347.
14. Shah D, Turnbull CJ. Type 2 diabetes mellitus and thyrotoxicosis presenting concurrently. Int J Clin Pract. 2002;56: 701-703.
15. Solá E, Morillas C, Garzón S, Gómez-Balaguer M, Hernández-Mijares A. Association between diabetic ketoacidosis and thyrotoxicosis. Acta Diabetol. 2002;39: 235-237.
16. Yeo KF, Yang YS, Chen KS, Peng CH, Huang CN. Simultaneous presentation of thyrotoxicosis and diabetic ketoacidosis resulted in sudden cardiac arrest. Endocr J. 2007;54:991-993.
17. Bech K, Damsbo P, Eldrup E, et al. Beta-cell function and glucose and lipid oxidation in Graves' disease. Clin Endocrinol (Oxf). 1996;44:59-66.
18. Beer SF, Parr JH, Temple RC, Hales CN. The effect of thyroid disease on proinsulin and C-peptide levels. Clin Endocrinol (Oxf). 1989;30:379-383.
19. Dimitriadis G, Baker B, Marsh H, et al. Effect of thyroid hormone excess on action, secretion, and metabolism of insulin in humans. Am J Physiol. 1985;248:E593-E601.
20. Roubsanthisuk W, Watanakejorn P, Tunlakit M, Sriussadaporn S. Hyperthyroidism induces glucose intolerance by lowering both insulin secretion and peripheral insulin sensitivity. J Med Assoc Thai. 2006;89(suppl 5): S133-S140.
21. Gonzalo MA, Grant C, Moreno I, et al. Glucose tolerance, insulin secretion, insulin sensitivity and glucose effectiveness in normal and overweight hyperthyroid women. Clin Endocrinol (Oxf). 1996;45:689-697.
22. O'Meara NM, Blackman JD, Sturis J, Polonsky KS. Alterations in the kinetics of C-peptide and insulin secretion in hyperthyroidism. J Clin Endocrinol Metab. 1993;76: 79-84.
23. Ohguni S, Notsu K, Kato Y. Correlation of plasma free thyroxine levels with insulin sensitivity and metabolic clearance rate of insulin in patients with hyperthyroid Graves' disease. Intern Med. 1995;34:339-341.
24. Holness MJ, Sugden MC. Continued glucose output after re-feeding contributes to glucose intolerance in hyperthyroidism. Biochem J. 1987;247:801-804.
25. Cavallo-Perin P, Bruno A, Boine L, Cassader M, Lenti G, Pagano G. Insulin resistance in Graves' disease: a quantitative in-vivo evaluation. Eur J Clin Invest. 1988;18: 607-613.
26. Shen DC, Davidson MB, Kuo SW, Sheu WH. Peripheral and hepatic insulin antagonism in hyperthyroidism. J Clin Endocrinol Metab. 1988;66:565-569.
27. Dimitriadis GD, Leighton B, Vlachonikolis IG, et al. Effects of hyperthyroidism on the sensitivity of glycolysis and glycogen synthesis to insulin in the soleus muscle of the rat [erratum in Biochem J. 1988;255:1061]. Biochem J. 1988;253:87-92.
28. Cachefo A, Boucher P, Vidon C, Dusserre E, Diraison F, Beylot M. Hepatic lipogenesis and cholesterol synthesis in hyperthyroid patients. J Clin Endocrinol Metab. 2001;86: 5353-5357.
29. Betley S, Peak M, Agius L. Triiodo-L-thyronine stimulates glycogen synthesis in rat hepatocyte cultures. Mol Cell Biochem. 1993;120:151-158.
30. Caro JF, Cecchin F, Folli F, Marchini C, Sinha MK. Effect of T3 on insulin action, insulin binding, and insulin receptor kinase activity in primary cultures of rat hepatocytes. Horm Metab Res. 1988;20:327-332.
31. Mokuno T, Uchimura K, Hayashi R, et al. Glucose transporter 2 concentrations in hyper- and hypothyroid rat livers. J Endocrinol. 1999;160:285-289.
32. Sestoft L, Christensen NJ, Saltin B. Responses of glucose and glucoregulatory hormones to exercise in thyrotoxic and myxoedematous patients before and after 3 months of treatment. Clin Sci (Lond). 1991;81:91-99.
33. Perez G, Ungaro B, Covelli A, et al. Altered glucoregulatory response to physiological infusions of epinephrine and glucagon in hyperthyroidism. J Clin Endocrinol Metab. 1980; 51:972-977.
34. McCulloch AJ, Johnston DG, Baylis PH, et al. Evidence that thyroid hormones regulate gluconeogenesis from glycerol in man. Clin Endocrinol (Oxf). 1983;19:67-76.
35. Shulman GI, Ladenson PW, Wolfe MH, Ridgway EC, Wolfe RR. Substrate cycling between gluconeogenesis and glycolysis in euthyroid, hypothyroid, and hyperthyroid man. J Clin Invest. 1985;76:757-764.
36. Hagenfeldt L, Wennlund A, Felig P, Wahren J. Hepatic gluconeogenesis and ketogenesis in hyperthyroidism. Life Sci. 1981;28:1851-1856.
37. Sato T, Saito S, Kokubun M, et al. Gluconeogenesis from glycerol and alanine in thyrotoxicosis. Tohoku J Exp Med. 1980;132:369-373.
38. Weinstein SP, O'Boyle E, Haber RS. Thyroid hormone increases basal and insulin-stimulated glucose transport in skeletal muscle. The role of GLUT4 glucose transporter expression. Diabetes. 1994;43:1185-1189.
39. Dimitriadis G, Parry-Billings M, Bevan S, et al. The effects of insulin on transport and metabolism of glucose in skeletal muscle from hyperthyroid and hypothyroid rats. Eur J Clin Invest. 1997;27:475-483.
40. Dimitriadis GD, Raptis SA. Thyroid hormone excess and glucose intolerance. Exp Clin Endocrinol Diabetes. 2001;109(suppl 2):S225-S239.
41. Laville M, Riou JP, Bougneres PF, et al. Glucose metabolism in experimental hyperthyroidism: intact in vivo sensitivity to insulin with abnormal binding and increased glucose turnover. J Clin Endocrinol Metab. 1984;58:960-965.
42. Barzilai N, Cohen P, Barzilai D, Karnieli E. Increased insulin responsiveness and insulin clearance in thyrotoxicosis. Isr J Med Sci. 1985;21:722-726.
43. Al-Shoumer KA, Vasanthy BA, Al-Zaid MM. Effects of treatment of hyperthyroidism on glucose homeostasis, insulin secretion, and markers of bone turnover. Endocr Pract. 2006;12:121-130.
44. Paul DT, Mollah FH, Alam MK, Fariduddin M, Azad K, Arslan MI. Glycemic status in hyperthyroid subjects. Mymensingh Med J. 2004;13:71-75.
45. Short KR, Nygren J, Nair KS. Effect of T(3)-induced hyperthyroidism on mitochondrial and cytoplasmic protein synthesis rates in oxidative and glycolytic tissues in rats. Am J Physiol Endocrinol Metab. 2007;292:E642-E647.
46. Chiasson JL, Shikama H, Chu DT, Exton JH. Inhibitory effect of epinephrine on insulin-stimulated glucose uptake by rat skeletal muscle. J Clin Invest. 1981;68:706-713.
47. Dimitriadis G, Maratou E, Alevizaki M, et al. Thyroid hormone excess increases basal and insulin-stimulated recruitment of GLUT3 glucose transporters on cell surface. Horm Metab Res. 2005;37:15-20.
48. Dimitriadis G, Maratou E, Boutati E, et al. IGF-I increases the recruitment of GLUT4 and GLUT3 glucose transporters on cell surface in hyperthyroidism. Eur J Endocrinol. 2008;158:361-366.
49. Jenkins RC, Valcavi R, Zini M, et al. Association of elevated insulin-like growth factor binding protein-1 with insulin resistance in hyperthyroidism. Clin Endocrinol (Oxf). 2000;52:187-195.
50. Dimitriadis G, Mitrou P, Lambadiari V, et al. Insulinstimulated rates of glucose uptake in muscle in hyperthyroidism: the importance of blood flow. J Clin Endocrinol Metab. 2008;93:2413-2415.
51. Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 2001;7:941-946.
52. Altinova AE, Törüner FB, Aktürk M, et al. Reduced serum acylated ghrelin levels in patients with hyperthyroidism. Horm Res. 2006;65:295-299.
53. Flanagan DE, Evans ML, Monsod TP, et al. The influence of insulin on circulating ghrelin. Am J Physiol Endocrinol Metab. 2003;284:E313-E316.
54. Möhlig M, Spranger J, Otto B, Ristow M, Tschöp M, Pfeiffer AF. Euglycemic hyperinsulinemia, but not lipid infusion, decreases circulating ghrelin levels in humans. J Endocrinol Invest. 2002;25:RC36-RC38.
55. Saad MF, Bernaba B, Hwu CM, et al. Insulin regulates plasma ghrelin concentration. J Clin Endocrinol Metab. 2002;87:3997-4000.
56. Caminos JE, Seoane LM, Tovar SA, Casanueva FF, Dieguez C. Influence of thyroid status and growth hormone deficiency on ghrelin. Eur J Endocrinol. 2002;147: 159-163.
57. Giménez-Palop O, Giménez-Pérez G, Mauricio D, et al. Circulating ghrelin in thyroid dysfunction is related to insulin resistance and not to hunger, food intake or anthropometric changes. Eur J Endocrinol. 2005;153:73-79.
58. Braclik M, Marcisz C, Giebel S, Orzel A. Serum leptin and ghrelin levels in premenopausal women with stable body mass index during treatment of thyroid dysfunction. Thyroid. 2008;18:545-550.
59. Yang R, Barouch LA. Leptin signaling and obesity: cardiovascular consequences. Circ Res. 2007;101:545-559.
60. Wannamethee SG, Tchernova J, Whincup P, et al. Plasma leptin: associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease. Atherosclerosis. 2007;191:418-426.
61. Iglesias P, Alvarez Fidalgo P, Codoceo R, Díez JJ. Serum concentrations of adipocytokines in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function. Clin Endocrinol (Oxf). 2003;59:621-629.
62. Pinkney JH, Goodrick SJ, Katz J, et al. Leptin and the pituitary-thyroid axis: a comparative study in lean, obese, hypothyroid and hyperthyroid subjects. Clin Endocrinol (Oxf). 1998;49:583-588.
63. Sreenan S, Caro JF, Refetoff S. Thyroid dysfunction is not associated with alterations in serum leptin levels. Thyroid. 1997;7:407-409.
64. Valcavi R, Zini M, Peino R, Casanueva FF, Dieguez C. Influence of thyroid status on serum immunoreactive leptin levels. J Clin Endocrinol Metab. 1997;82:1632-1634.
65. Cabanelas A, Lisboa PC, Moura EG, Pazos-Moura CC. Leptin acute modulation of the 5'-deiodinase activities in hypothalamus, pituitary and brown adipose tissue of fed rats. Horm Metab Res. 2006;38:481-485.
66. Lisboa PC, Oliveira KJ, Cabanelas A, Ortiga-Carvalho TM, Pazos-Moura CC. Acute cold exposure, leptin, and somatostatin analog (octreotide) modulate thyroid 5'-deiodinase activity. Am J Physiol Endocrinol Metab. 2003;284: E1172-E1176.
67. Cabanelas A, Lisboa PC, Moura EG, Pazos-Moura CC. Acute effects of leptin on 5'-deiodinases are modulated by thyroid state of fed rats. Horm Metab Res. 2007;39: 818-822.
68. Heidemann C, Sun Q, van Dam RM, et al. Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women. Ann Intern Med. 2008;149:307-316.
69. Altinova AE, Törüner FB, Aktürk M, et al. Adiponectin levels and cardiovascular risk factors in hypothyroidism and hyperthyroidism. Clin Endocrinol (Oxf). 2006;65:530-535.
70. Dimitriadis G, Mitrou P, Lambadiari V, et al. Glucose and lipid fluxes in the adipose tissue after meal ingestion in hyperthyroidism. J Clin Endocrinol Metab. 2006;91: 1112-1118.
71. Ardawi MS, Khoja SM. Effects of hyperthyroidism on glucose, glutamine and ketone-body metabolism in the gut of the rat. Int J Biochem. 1993;25:619-624.
72. Stevenson HP, Archbold GP, Johnston P, Young IS, Sheridan B. Misleading serum free thyroxine results during low molecular weight heparin treatment. Clin Chem. 1998;44:1002-1007.